Rosetta Genomics has developed several proprietary technologies that enable the Company to work with microRNAs.
Once microRNAs are extracted, Rosetta Genomics' technology is capable of detecting and quantifying the microRNAs using two custom designed platform technologies which utilize Quantitative Real Time PCR (or qRT-PCR) and microarrays [REF].